Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Ireland Prepares New Biosimilar Policy To Improve Access, Boost Industry

Executive Summary

Ireland is developing a new policy intended to increase the use of biosimilars, taking account of initiatives in other countries. The government says the aim is to help boost competition and access to cheaper biologicals.


Related Content

Biosimilar Firms Say Irish Price Deal Hinders Uptake, As Govt Plans New Policy Measures
Irish Drug Prices Face Annual Cuts Under New Four-Year Deal


Related Companies